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Abstract 
Microfibers have received much attention due to their promise for creating flexible and highly 
relevant tissue models for use in biomedical applications such as 3D cell culture, tissue 
modeling, and clinical treatments. A generated tissue or implanted material should mimic the 
natural microenvironment in terms of structural and mechanical properties as well as cell 
adhesion, differentiation, and growth rate. Therefore, the mechanical and biological properties of 
the fibers are of importance. This paper briefly introduces common fiber fabrication approaches, 
provides examples of polymers used in biomedical applications, and then reviews the methods 
applied to modify the mechanical and biological properties of fibers fabricated using different 
approaches for creating a highly controlled microenvironment for cell culturing. It is shown that 
microfibers are a highly tunable and versatile tool with great promise for creating 3D cell 
cultures with specific properties.   
1. Introduction 
 
Fibrous systems have numerous biomedical applications biomedical engineering, clinical 
treatments, and 3D cell culturing and cell encapsulation.[1-4] Since the surface area-to-volume and 
strength-to-weight ratios of the fibers are high, they offer a highly useful and strong method for 
creating large-scale 3D tissue cultures.[5] They have the potential to guide cell growth, alignment, 
and migration. Additionally, the microfibers can be applied in order to perform drug delivery and 
time-controlled release of a variety of a variety of chemicals and materials for culturing and 
therapeutic applications.[6, 7] 
The mechanical properties of the fiber are important, since in biomedical areas, it is 
desirable to mimic the mechanical characteristics of natural tissues. In skeletal muscle tissue 
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engineering (SMTE), for example, the goal is to re-engineer damaged muscle tissues.[8] In order 
to regenerate the skeletal muscle tissue, it is necessary that the myoblast align on a scaffold to 
mimic the natural microenvironment. This area can also be applied in bio-robotics,[9] bio-
sensing,[10, 11] cell-based assays,[12] and energy harvesting.[13-15] Additionally, scaffolds play a 
pivotal role in nerve tissue regeneration and modeling by providing an appropriate environment 
for cell adhesion and proliferation.[16-20] 
Fibers are well suited for use in biomedical applications, since they consist of a group of 
three-dimensional polymeric materials which have a hydrophilic structure which can hold large 
amount of water.[21] During the past decades in biomedical engineering, fibers were used as in vitro 
tissue models instead of native tissues due to the biocompatibility, ability to encapsulate bioactive 
molecules and cells and the efficient diffusion mass transfer of the hydrogels and polymers which 
form the fibers.[22] Cell-laden fibers can be divided into two main types: encapsulation type and 
surface type. Encapsulation type, where the cells are encapsulated within the body of the fiber, can 
be advantageous because the cells form a three-dimensional culture that mimic tissues in vivo. The 
mechanical tension of the fibers can be a technical problem with culturing cells within a fiber 
because of the cell-derived extracellular matrix (ECM) that is secreted from the cells.[23] 
Alternatively, surface type cell-laden fibers have cells seeded on the surface of the fibers, which 
requires that the surface be cell-adhesive. Because the cells are seeded on the surface of the fibers, 
handling of surface type cell-laden fibers must to be delicate because the cells are exposed to the 
outside environment. 
Although fibers can provide a desirable microenvironment which to emulate cell-cell and 
cell-ECM interactions, they can exhibit low mechanical properties and the appropriate mechanical 
strength might be found wanting.[24] Therefore, to provide better mechanical properties for 
 
4 
 
biomedical applications, synthetic polymers have been used to create fibers.[22, 25] This review aims 
to discuss different materials used and methods applied to improve the mechanical and biological 
properties of the fibers. While other reviews adequately cover topics ranging from microfibers’ 
use in biomedical applications,[26] hydrogels in biology and medicine,[22] and scaffolding in tissue 
engineering,[17, 20] this paper stands alone in its comprehensive one-stop approach to fiber 
fabrication. This paper provides details for creating fibers, highlights some common polymers for 
fiber creation, and gives an in-depth discussion over prominent biomedical applications. 
2. Methods of Microfiber Creation 
 
There are different methods for microfiber fabrication such as microfluidic techniques, 
Interfacial Polyelectrolyte Complexation (IPC), electrospinning,  microfluidic spinning, drawing, 
wetspinning, meltspinning, and biospining.[27]  Each of these techniques are discussed more 
thoroughly below.  
2.1 Microfluidic Technique 
 
The most common method to fabricate microfibers for biomedical applications is called 
laminar flow or microfluidic fiber fabrication.[26, 28] In this approach, the fiber is created within a 
microchannel using coaxial flow of core (pre-gel) and sheath (gelator) fluids. Microchannels can 
be formed using embedded syringe needles or glass capillaries, or polydimethylsiloxane (PDMS) 
devices, which can be created from molds made with standard microfabrication techniques such 
as milling or photolithography.  
Fiber polymerization in the laminar flow method can be accomplished via either chemical 
crosslinking or photopolymerization.[29] In chemical crosslinking, the pre-gel and gelator solutions 
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flow through the microfluidic channel in coaxial or parallel laminar flow.[26, 30] Exchange of ions 
or molecules occur via diffusion at the interface of the two distinct fluid flows, which leads to the 
polymerization of the pre-gel solution, and therefore the creation of the microfiber.[26] 
Alternatively, photopolymerization may be used to create the fiber from a microfluidic device. In 
this procedure, a photoinitiator (PI) is introduced into the pre-gel material, and the flow of the 
monomer solution is irradiated with ultraviolet (UV) light. After being irradiated, the PI causes 
crosslinking to occur within the pre-gel, and a polymer is formed.  
The laminar flow procedure is advantageous over other methods because it gives precise 
control of the diameter and cross-sectional shape of the resulting microfibers.[26] This can be 
accomplished by varying the microfluidic channel dimension and shape, as well as modifying the 
pre–gel and gelator solutions’ flow rates.[26] Moreover, the control of the alignment of the internal 
molecular direction can be achieved by the acceleration and deceleration of the flow,[31, 32] which 
affects physical characteristics of the microfiber such as the optical polarization, electrical 
conductance and this process induces cell alignment that are on and inside the microfibers.[33, 34] 
The fibers created by this method are versatile and the process is continuous. Additionally, 
this technique is straightforward, cost-efficient, and compatible with many biological materials 
due to the fact that high temperature, high pressure, high voltages, or toxic materials are not 
required.[35] Different shapes, sizes, and morphologies can be obtained by changing the flow rate 
ratio, varying the concentration of the pre-gel material in the core fluid, and changing the shape or 
dimensions of the microchannel.[1, 23, 28, 36-42] Many studies showed that different kinds of 
microfibers can be achieved using this method such as: solid,[28, 36, 39, 43, 44] tubular,[45, 46] hybrid,[47] 
and flat.[48, 49] Each is advantageous for various biomedical applications. 
The advantages of microfluidic spinning specifically in the domain of cell encapsulation 
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includes: production of fibers with diverse morphology;[50] cell immobilization in solid or hollow  
configurations of fibers;[16]  and formation of microchannel due to the elimination of alginate fibers 
from the 3D matrix.[50-55] Cell encapsulation via microfluidic spinning has been used for the in 
vitro reconstruction of complex 3D tissues emulating organs like the pancreas and improving 
immunity.[29] 
2.2 Wetspinning 
 
Wetspinning is an approach in which a pre-gel solution is injected into a coagulation 
bath, which must be either a poor solvent or a non-solvent with respect to the polymer. The 
method is capable of making fibers with a wide range of diameters by simply adjusting size of 
the needle tip. The major challenge of using this method is that the pre-gel solution must be 
exposed to chemicals for a relatively long time, increasing the likelihood that the fibers will be 
placed in a situation which is not friendly to cells, either through increased toxicity, change in 
temperature or CO2 level.[56-58] 
2.3 Interfacial Polyelectrolyte Complexation (IPC) 
 
In IPC fiber production, two oppositely charged polyelectrolyte solutions interact with one 
another, leading to the formation of polyelectrolyte complex at the interface.[59] It is crucial that 
the two solutions do not mix prematurely, and this is ensured by the interfacial complex that takes 
the place of a viscous barrier between drops of both solutions. Forceps or pipette tips are used to 
draw the interfacial complex upwards, which causes the disruption of the interface and creates 
scattered domains of complexation that behave as fiber nucleation sites. The exhaustion of the 
surrounding polyelectrolyte solution leads to the growth of nuclear fibers. As the mixed solution 
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is drawn away from the interfacial complex, nuclear fibers join together to form a final, thicker 
fiber. This thicker fiber constitutes submicron nuclear fibers and gel droplets along its axis.  
Wan et al. found that IPC fibers had more favorable mechanical properties than their 
original constituent polymers.[59] For instance, the tensile strength of chitosan-gellan fibers is 38.6 
kg/mm2 whereas chitosan fibers spun from dilute acid has a tensile strength of 23.7 kg/mm2.[60] 
Multi-Interfacial Polyelectrolyte Complexation (MIPC), in which the fiber is formed from the 
interfaces of multiple droplets of oppositely charged solutions placed against each other,  has also 
proven advantageous for creating 3D patterned co-culture of cells which featured a variety of cell 
types that were encapsulated in desired patterns.[61, 62] These experiments also revealed the cell 
migration, assembly and spreading within the fibers and also the process by which the traits were 
comparable to cell patterning. Tissue constructs having greater complexity and function can be 
created using MIPC. IPC fibers have the ability to create a conducive matrix for cell growth and 
differentiation, although to imitate the structure and function of a native tissue multiple cell types 
are generally required. MIPC fibers have been predicted to have a great use in biomedical 
applications especially of model system for cell biology and there are also used as basic 
components for the fabrication of human organs and tissues. IPC fibers are also used as drug 
delivery devices, light emitting diode and antireflection coating.[63-68] Syringe pumps and 
microfluidic channels are not required by this method.[26] Pre-gel solutions possessing polymers 
having high molecular weight not easily mixed by diffusion, can be treated using MIPC. 
2.4 Electrospinning 
 
Another method commonly used for the creation of micro- and nanofibers is 
electrospinning. Electrospinning is used due to its ability to create fibers consistently with highly 
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controllable morphologies. By varying the solution, process parameters, and environmental 
conditions, a variety of fiber types can be created. These fibers can be used for a huge variety of 
unique applications including: highly porous, defect free, non-woven nanofiber membranes used 
for water filtration;[69] in situ encapsulation of fungi enzymes;[70] and flexible, releasable guides 
for enhanced bone regeneration.[71] This small sample of the wide variety of application areas 
demonstrates the potential for a wide variety of uses for electrospun microfibers.  
The polymer solution in the syringe is slowly ejected into the electric field created 
between the needle tip and the grounded collector.[50] Different collector types allow for different 
fiber uses. Fibers collected on a rotating drum as shown are collinear; however collecting on a 
shaker bed can create meshes. The needle tip is connected to a high voltage electric field. That 
electric field begins elongating the droplet of polymer being ejected from the syringe forming a 
Taylor cone until the equilibrium with the surface tension the polymer solution is overcome. The 
static imbalance allows the polymer to jet towards the collector drum. Because the fibers 
inherently have a very high surface area to volume ratio, the solvent evaporates out of the fiber in 
the jet stream before it collects on the drum. 
The morphology and material properties of the resultant fibers are dependent on the careful 
tuning of working parameters including polymer solution concentration, polymer molecular 
weight, polymer viscosity, polymer solution surface tension, polymer solution conductivity, 
voltage, flow rate, collector type, tip to collector distance, and ambient parameters.[72]  With an 
abundance of controllable parameters significant advantages and limitations can be identified. The 
morphology of the fibers can be controlled through a wide range of sizes and shapes that allow for 
fibers that range from the nano- to microscale. The surfaces can also be controlled to include 
significant controllable porosity or exceptionally smooth surfaces depending on the application. 
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The process notably also allows for a large range of polymer materials to be used. The wide variety 
of materials makes the process incredibly flexible and adaptable. Inherent drawbacks to this 
process come from the many parameters that also make the processes controllable. Carefully 
monitoring and manipulating each of the parameters that controls morphology can be difficult to 
accomplish. The higher precision applications typically need highly controlled environments that 
stabilize fluctuating ambient conditions and can create highly complex electric field patterns to 
manipulate the shape of the fibers.  
2.5 Drawing  
 
Mechanical drawing has been termed as the simplest and most effectual basis for 
microfiber creation, since the microfiber is usually drawn from solvated liquid polymer.[73] The 
solvent nature and polymer concentration are the important concerns. This process is not the 
preferred method due to difficulty in controlling the fiber morphology compared to other 
processes.   
2.5.1 Drawing Using Glass Micropipettes  
 
In this process, the polymer solution is continuously pumped through a micropipette made 
of glass.[74] The pipette can be controlled using a nanopositioner and is positioned perpendicular 
to the substrate. The substrate is raised continually till it touches the polymer droplet that is present 
at the glass micropipette tip end. To have reliable droplet formation and adhesion, a solvophilic 
substrate is taken. Before laterally drawing a suspended fiber, the pipette is transported vertically 
with a constant speed and brought to a constant height. The viscosity of the polymer solution is 
controlled during the waiting time after stopping. The solid polymer fiber is formed by evaporation 
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of the solvent after the stage is transported along an established XYZ trajectory at a constant speed. 
The substrate is brought in contact with the glass micropipette after drawing the fiber, thereby 
creating a suspended fiber. Once completed the process can be repeated, causing a string of fibers 
to be generated along the substrate’s surface. For the final step, the needle is rapidly retracted 
causes it to lose contact with the droplet.  Fibers having lengths of several millimeters and 
diameters as low as 37 nm with one and two-dimensional network configurations could be 
fabricated using this method.  
2.5.2 Direct Drawing  
 
For direct drawing, the polymer solution heated to and maintained at a viscous state.[73] 
The tip of a heat-resistant rod, such as the end of a silica fiber, is immersed into the molten polymer 
before being slowly pulled away. As it moves away from the polymer it draws a thin fiber out of 
the surface of the molten polymer; this fiber can be quenched in air to induce rapid polymerization. 
The properties of fibers created with this method are affected by the pulling speed and the polymer 
viscosity.  
Fibers produced with this method have a variety of applications; for instance, Ong et al 
found that the fibers constructed from PMMA drawn with a 125 µm-wide Silica Fiber could bend 
and curl very easily thereby having a potential use in optical sensors. It was also noted that the 
diameter was uniform and the surface was defect free making them useful for photonic 
applications.[73] 
2.6 Meltspinning 
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Meltspinning is an approach in which continuous fibers are fabricated by heating a 
polymer to its melting point and extruding through a spinneret. While this method can be used to 
make a variety of synthetic fibers, it requires expensive equipment and a high temperature range 
(150 - 300 ˚C) in order to work.[75] High temperatures are known to damage cells and proteins, 
which means that meltspinning has limited applications for biomedical research or cell 
encapsulation applications.[76-78] The mechanical properties of the fibers made by this method are 
relatively low due to the rapid decrease of polymer viscosity during the process.[79] In addition, a 
high pressure gradient is required to move the melted polymer through the spinneret, which 
would cause potential harm for encapsulated cells.[80] 
2.7 Biospinning 
 
In the biospinning method, silk fibers are fabricated by insects. The tensile strength and 
biodegradability of silk is high. Additionally, it is not cytotoxic or inflammatory. Nevertheless, 
we face the limitation of resources for biospun fibers and the speed of fiber fabrication in this 
method is relatively slow, and so it is difficult to scale-up the process.[81, 82] In the interfacial 
complexation method, two polyelectrolyte solutions oppositely charged are applied and the fibers 
are created at the interface of two polyelectrolyte solutions.[83] Different polyelectrolyte solutions 
are used in this technique such as chitosan, sodium alginate, and hyaluronic acid.[83-85] This 
method can be applied for cell encapsulation purposes. However, in this method the variety of 
the materials that can be used for fiber fabrication is limited.  
3. Biomedical and Mechanical Properties of Select Polymers 
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A variety of microfiber have broad potential applications in biomedical engineering, with 
the merit of their biocompatibility, biodegradability and mechanical property.[86] The most 
researched microfibers include poly(lactic-co-glycolic acid)  (PLGA),[1, 87-92] poly(ε-
caprolactone)  (PCL),[3, 93-96] gelatin methacryloyl  (GelMA),[97-101] alginate,[44, 53-55, 102-105] 
chitosan,[60, 64, 106-109] and more. To provide context for material properties of these biomedical 
microfibers, in the following section, the polymeric structure, biomedical property 
(biocompatibility, biodegradability, etc.) and mechanical property of select biocompatible 
polymers Poly(lactic-co-glycolic acid), Poly(ε-caprolactone), Gelatin Methacryloyl, Alginate and 
Chitosan will be reviewed.  
Poly(lactic-co-glycolic acid), or poly(lactide-co-glycolide (PLGA) is a copolymer formed 
from lactic and glycolic acid.[88]  It is favorable for use in biomedical applications due to its 
approval for clinical use in humans by the U.S. Food and Drug Administration and its ability to 
be dissolved by a wide range of different common solvents.[90]  Its uniquely controllable 
degradation rates can be modified by varying the concentration ratio of its two monomers within 
the polymeric chain, rendering various forms of PLGA that exhibit different physicochemical 
properties.  Downsides to working with PLGA include its poor osteoconductivity and its low 
mechanical properties, which are not ideal for load bearing functions.  To counter these negative 
characteristics, PLGA is often used alongside ceramics or fiber-active glass in order to optimize 
clinical application in bone regeneration.   
The fastest degradation rate is achieved by PLGA 50:50, a form of the copolymer that 
contains an equal concentration of the lactic acid monomer and the glycolic acid monomer 
within each chain.[90]  Aside from the peak degradation rate of PLGA 50:50, forms of PLGA will 
generally possess faster degradation rates as the concentration of glycolic acid increases in the 
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copolymer.  Along with the concentration, degradation rates are also dependent on the molecular 
weight of PLGA.  By increasing the molecular weight of PLGA, degradation rates have ranged 
from several weeks to several months.[88]  The molecular weight of PLGA varies between the 
different forms of the copolymer, which are governed by the number of monomers and the ratio 
of lactic acid (C3H6O3) to glycolic acid (C2H4O3) within the chain. 
PLGA is commonly used in three-dimensional scaffolding for enhancing cell culturing, 
namely in bone substitute constructs.[88] Its highly tunable degradation rates allow for another 
level of control over factors that affect cell viability, growth, and interaction within the body.[91] 
Throughout degradation, there are noticeable changes to the mechanical properties of PLGA 
polymers, as they proceed through three stages of degradation: I) Weight remains stable, 
dimension decreases; II) Mechanical properties decrease, stable weight and dimensions; and III) 
Weight and dimension decrease, acidic components of PLGA are released into the environment; 
if injected, interaction with bodily fluids will help to maintain a safe pH.  
 Poly(ε-caprolactone) (PCL) is a synthetic polymer known and favored for its high degree 
of biocompatibility and biodegradability.[5] Its slow and tunable degradation rates ensure cell and 
tissue viability, as it does not change the chemical environment of the fibers by a rapid 
degradation process. These extremely slow degradation rates also have potential applications for 
long-term and targeted drug delivery systems, but in general PCL is mixed with other polymers 
to ensure a more rapid degradation rate.[110] Additionally, PCL fibers have highly tunable 
porosity which is suspected to be positively correlated to fiber diameter within 
electrospinning,[111] and is negatively correlated to PCL concentration for fibers created with the 
microfluidic approach.  
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Although pure PCL has a low tensile strength, its high elasticity still gains favor for use 
in biomedical engineering.[110] PCL fibers have been generated through electrospinning,[111] 
microfluidics,[5, 94, 112] and wetspinning.[113] They have been used for engineering model tissues 
of muscle cells,[113] neuronal stem cells,[94] and soft tissue cells.[111] Additional research indicates 
that PCL fibers created with different methods, such as different fluid flow rate ratios within the 
microfluidic fiber creation method, affect the behavior of cells along the fibers.  
 Gelatin Methacryloyl (GelMA) is a series of cross linked hydrogels that holds properties 
of both gelatin solutions as well as methacryloyl groups. At the microscale level, GelMA is a 
very morphable material, making it popular for tissue engineering and the study of controlled 
cell behavior. Its spatial versatility allows for it to be formed into a wide range of shapes and 
structures to mimic properties of the native extracellular matrix (ECM).  GelMA scaffolds also 
allow for cell proliferation, since they contain cell-attachment and matrix metalloproteinase 
responsive peptide motifs, as well as arginine-glycine-aspartic acid sequences.[97] GelMA is 
typically polymerized through photocrosslinking, which is favored due to its ability to work at 
mild temperatures and neutral pH values. Common photoinitiators (PIs) include 2-hydroxy-1-[4-
(2-hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959), lithium acylphosphinate salt 
(LAP), and 2,2-Azobis (2-methyl-N-(2-hydroxyethyl)propionamide).[97, 114]  However, 
photocrosslinking can be detrimental to cell encapsulation efforts if working with a cell line 
which is sensitive to UV light. GelMA has been used to mimic a variety of tissue types, 
including ocular,[101] cardiovascular ,[99, 100] and bone.[115] 
 GelMA’s mechanical properties are highly tunable, and can be affected by the amount of 
methalcryloyl substitution, the concentration of GelMA and PI the pre-polymer solution, and 
time of UV photopolymerization.[97] For instance, increasing the amount of methalcryloyl 
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substitution is linked to a decrease in the average pore size of the hydrogel, as well as 
proportionally increasing the compressive modulus and decreasing the swelling ratio. Certain 
post-processing techniques can also change the physical properties of the hydrogel; cryogenic 
treatments are linked to increasing the porosity of the surface of GelMA polymers.  
 Alginate, which is derived from seaweed, is made up of β-d-mannuronate (M) and α-l-
guluronate (G) links that are often either block chains such as (AAA-BBB-AAA-BBB) or 
randomly chained polymers.[102]  The physical form of Alginate is a gel-like substance and the 
specific characteristics of the natural polymer vary depending on the length of the polymeric 
chains and the concentrations of the links within the chain.  Alginate is favored for use in healing 
of secreting lesions, as it creates a moist environment that promotes cellular regenerative 
processes.  The gel-like textures and traits of Alginate are especially prevalent when applied to 
the wound due to the ion transfers between the alginate and the bodily fluids.  Alginate also has a 
low toxicity and high tissue compatibility, which make it advantageous for application to open 
wounds, cell encapsulation and subcutaneous injection into living hosts.[116] 
Gelation of alginate occurs via a chemical interaction wherein divalent cations bind to 
guluronate, which causes chaining to occur within the solution, thereby polymerizing the 
material.[116]  Common cross-linkers include Na+, Ca2+, Cu2+, Zn2+ and other cations to optimize 
tensile strength and hydration properties.[102] Choice of cross-linker play a crucial role in 
determining the physical properties of the resulting hydrogel, as seen in Figure 1.[105] For 
instance, using a cross-linker yields a film with a significantly higher tensile strength than a film 
created solely from Sodium Alginate (SA) which was polymerized via thermal crosslinking. 
Likewise, the presence of excess sodium during crosslinking affected the percentage of cross-
linking cations present within the final sample, which causes significant differences in the 
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mechanical properties of the resulting hydrogel. Some properties affected include the tensile 
strength, and the elastic modulus and percent elongation at break, which can be observed in 
Figure 1.  
 
Figure 1 Changes in elastic modulus and percent elongation at break for films polymerized with different cations. Significance 
was denoted with the symbol ★, with each label referring to the following comparisons: 1: each of the film compared with SA 
film polymerized via thermal crosslinking; 2: Ca-F compared against Ca-FN, 3: each of the film compared with SA, 4: Ca-F 
compared against Cu-F or  Zn-F; 5: Zn-FN or Zn-F compared with the rest of the films; and 6: CaZn-F compared with Zn-F 
Reproduced with permission.[105] Copyright 2012, Elsevier. 
 Chitosan is another polymer commonly used in tissue regeneration and localized drug 
delivery.[106, 108]  It is a naturally-derived polymer with a high degree of biocompatibility and 
degradability within the human body, as well as exhibiting hydrophilicity, functional amino 
groups and a cationic charge. These factors make it an ideal candidate for tissue engineering, and 
can be used for clinical applications such as therapeutics, subcutaneous injection, and oral 
delivery. It is also utilized for its ability to aid in cell transportation, since it can easily be 
processed into porous structures that can be used to create cell-permeable scaffolding.   
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 Another incentive to use Chitosan includes the variety of ways in which it can be 
polymerized.[106] Gelation can be induced via chemical interaction, or thermal polymerization. 
Thermal polymerization of Chitosan is a reversible process; the solution remains liquid at room 
temperature but the onset of polymerization occurs at 25 °C. This allows for unique applications, 
such as subcutaneous injection of liquid Chitosan which will gel as it warms up to body 
temperature. Chitosan is often partially acetylated to produce a lower form of crystallinity.[108]  
When fully acetylated or fully deacetylated, chitosan exhibits a maximum crystallinity, whereas 
lesser crystallinity occurs at degrees of acetylation between zero and one hundred percent.  
Chitosan also carries a high charge density when in solution, which enables it to form insoluble 
ionic complexes with many different water-soluble anionic polymers. 
4. Approaches for Improving Fiber Properties 
 
As mentioned above, there are a variety of microfiber fabrication techniques, each of 
which creates unique fibers. Therefore, there are many ways to produce fibers with desired 
properties.  This review aims to provide a comprehensive idea about methods for generating 
fibers with a wide range of mechanical properties, allowing for researchers to generate fibers 
with those properties that will be of most use in their respective fields.  
4.1 Changing the Polymer Concentration  
 
This approach can be applied in most of the fiber fabrication methods. In a study, Bai et 
al. fabricated gelatin fiber using the microfluidic fiber fabrication. In this paper, gelatin was 
dissolved in Dimethyl sulfoxide (DMSO) as the prepolymer solution (core fluid) with the 
concentration range of 8% to 12% that results in a wide range of core fluid viscosity from 446 to 
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5140 cP.[28] 
 
Figure 2 (a) 8%, (b) 9%, (c) 10%, (d) 11%, and (e) 12% gelatin concentration in DMSO. The flow rate of the core and sheath 
fluids are 5 mL min-1 and 1500 mL min-1, respectively (g) Stress-Strain curves of the gelatin microfibers fabricated with different 
gelatin concentrations in DMSO; the flow rate of the core and sheath fluids are 5 mL min-1 and 1500 mL min-1, respectively 
Adapted under the terms of the CC-BY-X license. [28] Copyright 2014, RSC.   
Figure 2 (a-f) exhibits the SEM images of the microfibers made by different concentrations 
of gelatin in DMSO with the core and sheath flow rates of 5 mL min-1 and 1500 mL min-1, 
respectively.[28] This figure shows that the increase of the gelatin concentration results in an 
increase of the fiber roughness. The mechanical properties of the fibers made by different gelatin 
concentrations are provided in Figure 2 (g). This figure indicates that the mechanical properties 
of the microfibers are improved significantly by increasing the gelatin concentration. 
Additionally, Figure 2 (g) and Figure 3 (e) show the results of changing the gelatin concentration 
in DMSO. Based on this table, the increase of the gelatin concentration from 8% to 12%, 
enhances the Young’s modulus and tensile stress at break by 2.2 and 1.9 times, respectively.   
4.2 Changing the Microfiber Shape 
 
In some of the microfiber fabrication methods, the shape of the fiber can be regulated by 
changing the variables involved. Microfluidic fiber fabrication is one the best techniques when 
 
19 
 
producing different shapes of the microfiber is desirable. Some reports showed that the shape of 
the microfiber can be easily changed by using different flow rate ratios between the core and 
sheath fluid.[28, 48] It was proven that decreasing the flow rate ratio between the core and sheath 
fluid results in the increase of the fiber aspect ratio and size (Figure 3 (a-d)).[28] Figure 3 (d) 
shows the direct relation between the flow rate ratio of two fluids and the size of the 
microchannel. The mechanical properties of the microfibers made by different flow rate ratios 
are shown in Figure 3 (e). This figure illustrates that the mechanical properties of the microfiber 
can be improved by decreasing the flow rate ratio of the sheath and core fluid as well as 
increasing the gelatin concentration in the core solution. 
 
Figure 3 SEM images of the gelatin microfiber made by 9% gelatin in the core solution and the flow rate ratios of (a) 150 : 1, (b) 
75 : 1, and (c) 30 : 1; (d) the relation between flow rate ratio and the cross section of the fiber; (e) the mechanical properties of 
the microfibers made by different flow rate ratios and gelatin concentrations Adapted under the terms of the CC-BY-X license. 
[28] Copyright 2014, RSC. 
Additionally, in microfluidic fiber fabrication the cross section of the microfiber can be 
dictated by the design of the microchannel. Boyd et al. used thiol−ene and thiol−yne pre-polymer 
solutions in order to fabricate fibers.[48] The SEM images of the microfibers made by two 
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different channels are provided in Figure 4 (a-d). This clearly demonstrate the ability of the 
microfluidic approach for making fibers with a wide range of aspect ratio. Figure 4 (e-f) shows 
the mechanical properties of the fibers made by thiol−ene and thiol−yne fibers, respectively. 
These figure exhibits that the stiffness of the round fibers is higher than that of the ribbon shaped 
fibers. Additionally, the thiol−yne fibers are stiffer than thiol−ene fibers.  
    
Figure 4 The SEM images of fiber cross section. (a) Round thiol-ene fiber made by two inlet channel and (b-d) ribbon-shaped 
fibers made by three inlet channel; (e) and (f) stress-strain curves of the thiol−yne and thiol−ene fibers, respectively. Adapted 
under the terms of the CC-BY-X license. [48] Copyright 2013, American Chemical Society 
4.3 Polymer Blending 
 
In tissue engineering, one of the goals is to improve the cell adhesion, differentiation, and 
growth rate. Hydrogels created by synthetic polymers are usually nontoxic, homogenous, and 
tunable in terms of mechanical and chemical properties.[117] Despite many advantages, the cell 
affinity toward the synthetic polymers is weaker than that of the natural polymers due to their 
low hydrophilicity.[118] The cell affinity can be improved by using bioactive proteins onto the 
(f) 
(e) 
 
21 
 
fibers.[93] Some studies proved that blending the synthetic and biological (BioSIN) polymers can 
modify the properties of the scaffold.[93, 96, 118, 119] In some studies, the design of the scaffold was 
optimized in terms of the percentages of the synthetic and natural polymers.[109, 120, 121] However, 
there is always the possibility of incompatibility between the natural and synthetic components, 
such as phase separation and insolubility. Ghasemi-Mobarakeh et al. used electrospinning 
approach to fabricate biocomposite PCL:Gelatin nanofibrous scaffolds with weight ratios of 
50:50 and 70:30.[119] The SEM images of the random and aligned PCL/gelatin nanofibers are 
shown in Figure 5.  
 
 
Figure 5 A) SEM images of the random and aligned PCL:Gelatin 50:50 nanofiber B) Tensile properties of PCL, PCL/gelatin 
50:50 and PCL/gelatin 70:30 nanofibers  Adapted with permission. [119]  Copyright 2008, Elsevier. 
In this study, the tensile properties of the electrospun PCL, PCL/gelatin 50:50 and 
PCL/gelatin 70:30 nanofibers were measured and the results are provided in Figure 5 (b).[119] The 
results demonstrate that the mechanical properties of the scaffold made by the nanofibers are 
(a) 
(b) 
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affected significantly by the percentage of the gelatin in the blend. The flexibility of the 
PCL/gelatin 70:30 nanofibers were higher than that of the PCL fiber whereas PCL/gelatin 50:50 
has weak mechanical properties. Therefore, the PCL/gelatin 70:30 nanofibers were applied for 
cell culture process since its cell adhesion properties is better than pure PCL and its mechanical 
properties does not change significantly.  
Daniele et al. applied thiol-click and photopolymerization simultaneously in order to 
create BioSIN macromalecular interpenetrating networks (IPNs) with desirable mechanical 
properties and cytocompatibility.[98] They integrated GelMA and PEG by concurrent 
photoinitiated thiol-click reactions. In this study, three different IPNs were fabricated by the 
covalent (BioSINx) and physical (BioSINp) incorporation of proteins with a synthetic polymer 
network. The third one was PEG-co-GelMA, which was made in order to compare the effect of 
additional thiol-yen versus the thiol-ene network. The compressive elastic modulus of the three 
networks with different compositions are shown in Figure 6. Generally, the elastic modulus of 
BioSIN is more than others and it increases by increasing the percentages of PEG and GelMA.  
 
Figure 6 Compressive elastic modulus (kPa) of (a) BioSINx, (b) PEG-co-GelMA, and (c) BioSINp Reproduced with 
permission. [98] Copyright 2014, Elsevier. 
The stress-strain curves of the BioSIN and neat hydrogels under uniaxial compression are 
provided in Figure 7 (a). This figure demonstrates that all of the formulations have a linear 
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region.[98] Additionally, in BioSINx and PEG-co-GelMA network, the modulus increases by 
increasing the strain whereas the modulus of BioSINp does not change significantly. The 
viscoelastic properties of different formulations are shown in Figure 7 (b). This figure indicates 
that the loss and storage modulus are independent of frequency for all of the networks. BioSINx 
shows an elastic behavior since its storage modulus is higher than its loss modulus whereas in 
BioSINp, the difference between these two modulus is lower compared to BioSINx.   
 
  
Figure 7 (a) stress-strain curves and (b) the viscoelastic properties of different formulations Adapted with permission. [98] 
Copyright 2014, Elsevier. 
4.4 Inclusion of Nanomaterial 
 
Many synthetic or natural polymers have been used to fabricate fibers in the biomedical 
engineering area. As mentioned above, the natural polymers have a better functionality in terms 
of cell affinity compared to synthetic polymers, but their mechanical properties and electrical 
conductivity are very weak. These shortcomings of natural polymers limit the application of 
natural polymers in adapting the cellular activity such as skeletal muscle cells.[122] Gelatin, for 
instance, is a biocompatible and biodegradable natural polymer, which is obtained from native 
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collagen.[123] Some studies show that the inclusion of nanomaterials is another way to improve 
the mechanical and biological properties of biomaterials. Another advantage of using this 
method is to increase the electrical properties of the polymers.[99] 
In one study, it was shown that the mechanical properties and conductivity of methacrylated 
gelatin (GelMA) hydrogels can be enhanced by adding carbon nanotubes (CNTs).[100] However, 
in this research, it was not possible to create the hydrogel with the shape of natural extracellular 
matrix (ECM). Ostrovidov et al. handled this problem and fabricated gelatin fibers using the 
electrospinning approach and cross linked them with glutaraldehyde (GTA) vapor followed by 
rinsing them in water for 2 days.[124] A schematic of electrospinning fiber fabrication method is 
illustrated in Figure 8 (a). Figure 8 (b and c) are TEM images of the gelatin fiber including the 
multi-walled carbon nanotubes (MWCNTs). The effect of MWCNT percentage on Young’s 
modulus of the gelatin nanofibers is demonstrated in Figure 8 (d-f). Based on this figure, the 
Young’s modulus for a gelatin nanofiber increases from 509 ±37 kPa (without MWCNT) to 
1077 ±266 kPa and 1170±168 kPa with 0.5 mg/ml and 5 mg/ml MWCNT, respectively.  
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Figure 8 (a) Schematic of electrospinning fiber fabrication method; (b and c) TEM images of the gelatin nanofiber that includes 
MWNTs; (d-f) Young’s modulus of the nanofibers made by 0 mg/ml, 0.5 mg/ml, and 5 mg/ml of MWNTs. Adapted under the terms 
of the CC-BY-X license.[124] Copyright 2011, Dove Medical Press Ltd. 
4.5 Using textile manufacturing processes 
 
It was recently found that the textile technologies have high potential to control the size, 
shape, and porosity of natural and synthetic fibers.[27, 125, 126] The textile technologies can 
essentially be divided into different types, such as weaving, knitting, and braiding.[23, 87] These 
technologies can be applied in order to mimic mechanical properties of natural tissues, such as 
cardiac muscle, tendon, and vascular walls.[87, 127, 128]  In a study, a 3D scaffold was made by 
weaving poly(glycolic acid) (PGA) microfibers.[129]  
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Figure 9 (a) Schematic of cell-laden composite living fibers (CLFs); (b) the experimental set-up; (c-e) fibers coated with 
hydrogel at different drawing speed.[130] 
The variables involved are the drawing speed and the polymer concentration.[130] The increase 
of the gel concentration and drawing speed results in increasing the thickness of the layers 
(Figure 9 (c-d)). After making CLFs, the most common textile manufacturing processes were 
applied in order to obtain different structures of the fibers.  
In this study, they used braiding technology to combine three different CFLs containing 
NIH 3T3 cells, HepG2 cells, and HUVECs, respectively in order to model the liver.[130] The 
tensile test was applied to compare the mechanical properties of the CFLs and alginate Figure 
10. The results of Young’s modulus and tensile tests reveal the possibility of obtaining a wide 
range of mechanical properties for the fiber by using braiding.  
 
Figure 10 (a) Young’s modulus and (b) stress-strain curve of braided CLFs and alginate fiber.[130] 
(a)  (b)
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5. Use in Biomedical Applications  
 
Fibers have enjoyed attention within biomedical fields, including biomedical engineering, 
due to their versatility and highly tunable mechanical properties, which allows for precise control 
over the microenvironment when used for cell culturing. They are favored within these fields for 
their ability to deliver cells to a specific target region in a targeted and protected matter, as well 
as providing support for tissue engineering purposes. Cell-laden fibers can be classified into two 
main types of culture: encapsulation type and surface type. Modifications to the topography and 
chemistry of the surface of the fibers can help to aid in cell adhesion, and creating a 3D structure 
of fibers can ensure a more physiologically correct model for use in biomedical research.  
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5.1 Encapsulation Type 
 
Figure 11 (a) Cells seeded on the surface of the fiber. (b) Encapsulated fibers: (i) standard, (ii) tubular, (iii) core‐shell and (iv) 
compartmentalized. (c) Myoblasts seeded on GelMA fibers (d) HUVEC cells encapsulated in GelMA microfibers. Scale bars (c) and 
(d) are 150 μm. [131] 
For encapsulation type cell-laden fibers, cells are originally dispersed in pre-polymer 
solutions and then after gelling the solutions the cells become encapsulated forming cell-laden 
fibers. As shown in Figure 11 (b), encapsulation type cell-laden fibers can have multiple fiber 
geometries including: standard, tubular, core-shell, and compartmentalized. An advantageous 
feature of encapsulation type fibers is that cells form a three-dimensional culture that mimic 
tissues in vivo. This provides a critical cell culture platform that contributes to a number of 
different fields of study.[26] The fiber material used in the fabrication process for encapsulation 
type cultures must, obviously, be biodegradable and non-toxic to the cells. Because of this, the 
mechanical tension of the fibers can be a technical problem with culturing cells within a fiber. As 
the cells spread and proliferate over time, the fiber often changes as the encapsulated cells 
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secrete extracellular matrix (ECM).[23] Conversely, if the polymer degradation happens too 
slowly, a buildup of ECM will occur and may influence cell function.[132] To maintain the shape 
of the cell construct long term, the main issues that are to be considered are: type of cells, and 
degradation speed and mechanical stiffness of the fiber material.[23] 
Successful encapsulation has occurred using a wide variety of materials and microfiber 
fabrication techniques. Perhaps the most common technique used for creating a variety of types 
of encapsulated fibers is the microfluidic technique, which is favored for this application due to 
the fact that it is capable of producing fibers in mild conditions with biocompatible materials,[24, 
25, 27] However, MIPC and Extrusion are also common methods for creating fibers with 
encapsulated cells. Electrospinning has also produced encapsulated fibers, but in this case 
caution must be used, since the diameter of electrospun fibers is typically smaller than that of the 
encapsulated cells.[27] Alginate is particularly suited for encapsulating cells due to its ability to 
polymerize under conditions which are appropriate to cell culturing; it is possible to ensure a 
neutral pH, and lower concentrations of Alginate do not need to be heated to ensure viscosity.[26]  
However, a wide variety of polymers have successfully encapsulated cells, including 
Poly(ethylene glycol) diacrylate,[121, 133, 134] PCL,[135, 136] Alginate,[53, 55, 116] and more.[26, 110] 
5.2 Surface Type  
 
Surface type cell-laden fibers have cells seeded on the surface of the fibers, which can be 
seen in Figure 11 A. This requires that the surface is cell-adhesive and biocompatible. For 
surface type cell-laden fibers, cells are not present during the production of the fibers; therefore, 
it is possible to use toxic solutions or severe conditions that might be harmful to cells. This 
expands the possibilities of different materials that can be used in surface type fibers. Because 
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the cells are seeded on the surface of the fibers, handling of the cell-laden fibers has to be 
delicate because the cells are exposed to the outside environment. 
5.3 Surface Properties of Fibers 
 
Using surface type fibers in biomedical applications can be difficult, as it requires cells to 
attach to the fibers’ surface. This process can be aided by modifying the chemical or 
topographical properties to produce a situation which encourages cellular attachment. 
Additionally, the topography and surface chemistry of the fiber plays a large role in the behavior 
and health of cells growing along its surface, and in controlling the differentiation of neural 
progenitor cells.[27] Modification of fibers’ surface environment can be accomplished by 
introducing chemicals or polymer bases to the surface of the fiber, or by changing the surface 
texture.  
One can change the chemical properties of the fibers through several procedures. An 
example of a cell adhesion component can be the addition of the oligopeptide sequence Arg-Gly-
Asp (RGD).[137]  Additionally, coating the surface with a component of the ECM can help by 
shifting the fibers to be more biologically compatible. In addition to modifying the surface with 
biological agents typically found in the cells’ native environments, it is possible to tether 
polymer chains onto the surface of fibers to enhance cell adhesion. For instance, researchers 
grafted poly(ethylene glycol) methacrylate chains onto the surface of electrospun fibers, which 
enhanced cell adhesion.[138] 
Researchers have also shown that changing the surface texture of the fibers aided with 
cell adhesion and adjusted cell behavior. For instance, creating grooves on the surface of the 
fiber not only helps with cell adhesion, but also aids in cell orientation. [104] An example of this 
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can be seen in Figure 12. 
 
Figure 12 Cell behavior on grooved fibers. Scale bars indicate 50 μm.[104] 
Another method for changing the surface of fibers includes increasing the porosity, which 
allows for homogeneous cell distribution and interconnection, as well as potentially aiding in 
nutritional diffusion to the cells.[25] There are multiple methods to adjust the porosity of fibers; 
for instance, it is possible to mix a dissolvable particle into the pre-gel solution which can then 
be washed out of the solidified fiber. Post-processing methods can also create porosity on fiber 
surfaces after their creation; these include freeze-drying the hydrogels, which causes 
thermodynamic instability and phase separation within the structure. Additionally, plasma 
etching can be used to modify the surface, which not only helps by causing fibers to become 
more hydrophilic and thereby increasing their interactions with biomolecules, but also by etching 
the surface and increasing wettability and roughness without influencing the bulk properties.[139, 
140] More modifications can be borrowed from surface engineering, such as: ion beam 
implantation, which promotes cell adhesion; electron beam texturing, which gives precise control 
of nano-features; and laser texturing, which provides precise control over even complex 
features.[141] 
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5.4 Fibrous Scaffolds  
 
Once fibers have the appropriate chemical and biocompatible properties, it is possible to 
use them to create 3D scaffolds to aid in the support and health of a 3D cell culture. This is 
preferred over 2D cell culturing techniques due to its increased physiological relevance. To create 
scaffolds, fibers of various surface topologies can be wound, woven, or manipulated as described 
above so that it gains a 3D component with a highly controllable microenvironment. Methods 
include circumferential winding, where a fiber is repeatedly wound around a base and allowed to 
dry. This forms a mesh of fibers, the width of which is determined by the number of rotations 
performed in the winding process.[142] Additionally, by alternating the pre-gel solution, it is 
possible to generate circumferential scaffolds with spatially distinct chemical or physical 
properties, thereby allowing for a more complex 3D environment for cell culturing or regenerative 
medicine.[143] 
Another method for the creation of scaffolding includes extruding the fiber onto a flat, 
mobile surface. As the fiber is created, the platform below it moves, causing it to fall in a uniformly 
flat mesh.[95] The height of these meshes can be adjusted by changing the amount of time the fiber 
is extruded, or by stacking multiple meshes on top of one another.  
Additional techniques to assemble fibrous scaffolds can be borrowed from the textile 
industry.[23] Weaving, knitting and braiding can affect the mechanical properties of a linear fiber, 
as discussed above, but can also be very effective when applied to the issue of creating a 3D 
culture. For instance, Onoe et al (2013) detail a method for creating woven 3D structures of 
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fibers, which can be seen in Figure 13 (a).[23] In the same paper, the group mentioned a method 
for creating helical fibrous scaffolds, which can be seen in Figure 13 (b).  
 
Figure 13 (a) (i) Method for weaving a 3D structure from fibers with a loom submerged in cell media; (ii) Example of woven 3D 
cell culture formed with fibers encapsulating three different cell lines. Scale bar represents 1 mm. (b) (i) Schematic for creating a 
helical fibrous scaffold, (ii) Resulting helical tube, created with two cellular fibers, one with NIH/3R3-ACol cells, and the other 
with HepG2-PCol fibers. Scale bars represent 1 mm Adapted with permission. [23] Copyright 2013, Nature Materials. 
There is also a possibility that IPC fibers can be used as a building block or ‘biostructural 
unit’ for engineering 3D constructs, For example, IPC fibers formed from water soluble chitin 
(WSC) and alginate was used to encapsulate cells and proteins while leaving the quality of the 
biologicals uncompromised.[62] In order to assemble these biostructural units in a spatially 
governed arrangement so as to attain multi-cellular tissue constructs multi – interfacial 
polyelectrolyte complexation (MIPC) can be used. In the MIPC process, there is fusion of various 
interfaces within the polyelectrolyte droplets in order to create an IPC fiber with several 
sections.[59] 
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In another study, knitting textile technology was applied to combine type I collagen and 
poly(lactic-co-glycolic acid) (PLGA) for the cartilage regeneration applications.[87] Akbari et al. 
fabricated the composite living fibers (CLFs) by passing the fibers into several reservoirs of cell-
laden prepolymer (Na-alginate) and crosslinking reagents (CaCl2).[130] The schematic of this fiber 
fabrication method and the experimental set-up are illustrated in Figure 9 (a) and (b), 
respectively. Some of the resulting scaffolding can be seen in Figure 14. 
 
Figure 14 Using the most common textile manufacturing types: (a) Weaving; (b) knitting; (c) braiding; (d) winding.[130] 
Fibrous scaffolds also allow for a tunable environment between the fibers, which affects 
the behavior and health.[94] It is known that even slight changes to the mechanical properties of a 
cells’ environment can affect their health and behaviors by changing the way they interact with 
their surroundings and each other.[144] Sharifi et al (2016) showed that scaffolds created with fibers 
of certain sizes allowed for cells to bridge across gaps within the scaffolding. The size of the fibers 
and the tightness of the scaffolding affects the density and amount of empty space within the 
scaffold, thereby affecting the 3D microenvironment through which the cells exchange nutrients 
and secrete signaling chemicals and waste. This plays an important role in determining cell health, 
but also could affect studies which aim to understand cell-to-cell interactions by examining the 
chemical makeup of the interstitial fluid within the scaffold. For this reason, it is crucial to design 
scaffolding with the original tissue environments and ECM matrices in mind, taking care to mimic 
the original architecture, bioactivities, and mechanical properties.[20] 
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5.5 Microfibers for Topical and Subcutaneous Drug Delivery and Regenerative Aides 
 
Another strong motivation to progress knowledge of biocompatible microfibers is the 
possibility of subcutaneous injection for targeted, time-controlled drug delivery or aided 
regenerative medicine. An example of a subcutaneously-injected electrospun fibrous scaffold can 
be seen in Figure 15. 
 
Figure 15 Electrospun poly(ester urethane) urea implanted into the abdominal wall of rats at time of implant (A) and after four 
weeks (B).  Reproduced with permission.[145] Copyright 2011, Elsevier. 
 Creating fibers for targeted drug delivery systems is accomplished by encapsulating the 
drug within the fiber; this can be done by injecting them within the core of hollow microfibers, 
encapsulating them like the cell encapsulation which was discussed at length previously, and 
crosslinking or absorbing the drugs on the surface of created microfibers.[144] Due to the potential 
sensitivities of therapeutic chemicals, only certain microfiber creation techniques are suitable for 
drug encapsulation. These include wet extrusion/spinning,[143, 144, 146] microfluidic fabrication,[43] 
and electrospinning.[104, 147, 148] Fibers or scaffolds injected into a patient might include a variety 
of therapeutic agents, including antibiotics, proteins, growth factors, genes, vitamins, liposomes, 
and chemotherapy medications.[6, 144, 149-151] 
5.5.1 Topical Drug Delivery and Wound Protection  
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Topical drug delivery systems remain on and are absorbed through the skin instead of entering 
the body through oral or subcutaneous injection. This system has some key advantages over 
internal drug delivery: it avoids the potentially harsh and changing environment within the body, 
it shows high levels of efficiency, treatment can be easily terminated at any time, and more.[152] 
However, difficulties arise due to the possibility of contact dermatitis, damage to the drug due to 
its interactions with the skin, and the inability to absorb large particles through the skin.   
 Topical fibrous treatments are typically used in healing wounds, where they can both 
protect damaged tissue and deliver medications to increase healing rate. They can take the form 
of sutures, which are used to hold the wound shut and therefore must have high tensile 
properties; wound dressings, which are temporarily attached to the surface of the wound; and 
grafts, which holds living tissue that will hopefully take the place of tissue which is missing due 
to injury or disease.[152, 153] Each of these must come in direct contact with a wound, and 
therefore must be stable and biocompatible so as not to further damage already injured tissues.  
 Suturing is a widely used and accepted method of treating a wound, such as a cut. Sutures 
are microfibers which must be strong, since they are being used to draw and hold wounded skin 
together, but they also must be able to stretch and recoil to accommodate the shifting of the 
wound and of the patient.[152] They can be made from both synthetic and natural polymers, and 
common methods of creation include dry spinning, melt spinning and gel spinning. 
Modifications include embedding antibiotics, and including radioactive isotopes. Examples of 
sutures include an absorbable poly(glycolic acid) (PGA) suture and poly(lactic acid) suture 
anchors; however, these are known to have poor interactions with cells, and therefore newer 
materials with more favorable surface chemistry have been generated.[154] 
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 Wound dressings come in a variety of types; passive dressings only cover the wound, 
while interactive dressings allow passage for water vapor and oxygen but protect the wound from 
damaging material, and bioactive dressings contain and provide helpful components to aid in 
healing.[152]  Micro- and nanofiber mats can be applied directly to the wound can allow for 
necessary evaporation and oxygen permeability, which provides a more ideal environment for 
wound healing. Fibrous mats which contain therapeutics can also create a bioactive dressing, 
with highly tunable characteristics for absorption and release of drugs, as well as of fluid from 
the wound.  
 Historically, grafts have constituted living tissue which has been relocated in order to aid 
in healing a wound. Typically grafts are taken from the patient in order to minimize threat of 
rejection or other post-surgery complications. However, microfibers may lead the way to a new 
generation of grafts which would nullify the need of harvesting healthy tissue, which by 
necessity would create another wound in the process. Inclusion or replacement of standard grafts 
with those created by fibers can create an ideal environment for healing while housing new cells 
which help to speed up the healing process. Skin grafts used on mice showed significant 
improvement in healing rates over untreated mice.[155] Additionally, microfiber composites show 
promise in increasing the effectiveness of vascular grafts.[153] 
5.5.2 Subcutaneous Injection for Drug Delivery and Regenerative Aide  
 Injection of both microfibers and fibrous scaffolds can be an excellent way to aid in 
tissue regeneration and provide targeted drug delivery.[35] However, any material injected into a 
living body must be both biocompatible and stable. Depending on the application it might also be 
necessary for injected microfiber and fibrous scaffolds to either degenerate safely or be 
reabsorbed into the body; if not, the injection would either be a permanent addition to the patient, 
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or would need to be removed at some later point.  
 Different applications may call for different volumes of injected material or amounts of 
therapeutic agent; therefore, it may be more advantageous to inject on the microfiber-scale or to 
go through the more invasive technique of injecting scaffolding. While microfibers are 
particularly well suited for targeted drug delivery, or for aiding in small-scale cellular 
regeneration and guiding, cases where larger volumes of tissue must be regenerated call for the 
insertion of a fibrous scaffold. Both microfibers and their 3D counterparts might be modified in 
any of the ways listed above, which can help to increase their hydrophilicity, change their 
mechanical properties, or adjust cell behavior as they interact with the surface of the fiber. 
Additionally, it should be noted that the addition of therapeutic chemicals may alter the 
mechanical properties of the fibers, including factors such as ultimate tensile strength (UTS) and 
strain at failure.[144] 
 Microfiber injection has been proposed for a variety of applications, including using 
wetspun Poly(l-lactic acid) fibers for targeted release of inflammatory drugs, which occurs 
linearly for up to 8 weeks in vitro.[144] Additionally, Lin et al. (2012) used the microfluidic 
method to create alginate microfibers whose release of drugs was controllable through magnetic 
stimulation; if left alone, the fibers released the drug diclofenac steadily, but the fibers 
experienced the application of an external magnetic field, they rapidly released diclofenac.[43]  
Injection of fibrous scaffolds can be a powerful technique to aid in regrowth of damaged 
tissue, and has shown promise for a wide variety of biomedical engineering applications. For 
instance, Park et al (2016) showed the efficacy of titanium microfiber scaffolds in aiding bone 
regeneration; furthermore, they showed that modifying the surface of the scaffold with long-term 
exposure to UV light improved its hydrophilicity and dramatically improved bone regeneration 
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and strength after implantation in vivo.[156]  Other researchers, such as Chet et al. (2017), have 
begun incorporating smart biomaterials into microfiber drug delivery by creating a microfiber 
mesh with the ability to release drugs in an electrically controlled manner.[148] These studies 
show high degrees of biocompatibility and excellent capabilities in time and location-controlled 
drug release. Likewise, injecting fibrous scaffolds of a variety of materials and creation methods 
has been utilized in areas such as smooth muscle,[107] soft tissue,[145] teeth,[92] and bone.[156, 157] 
Others have focused on using scaffolding for regenerative treatments for intervertebral disc 
tissues,[20] or creating viable tumeroid models for testing cancer treatments, including ones which 
might host cells gathered from biopsies for the generation of patient-specific treatment plans in 
clinical settings.[89] While scaffolding injections can provide critical tissue-specific clinical 
treatments, it should be noted that critical concerns have arisen over the gaps in mechanical 
properties needed for scaffolding to succeed as well as metallic stents.[158]  
 Scaffolding can gain another level of complexity, since they can also be modified to emit 
drugs and act as a therapeutic device. For instance, Ranganath and Wang (2008) mixed 
Paclitaxel, a drug used in chemotherapy, into the pre-gel solution before using electrospinning to 
create PLGA fibers.[147] They showed that Paclitaxel was released continuously over a span of at 
least 80 days, and the amount released varied based on the amount of available surface area over 
the different samples.  
Conclusions 
This review paper provided different methods that can be applied in order to regulate the 
mechanical and biological properties of microfibers for applications within biomedical 
engineering. The most common fiber fabrication methods have been discussed, as well as the 
parameters for tuning the properties of the fibers. There are some general modifying methods 
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that are functional for all of the fiber fabrication approaches. Through modifying the method of 
creation, materials, or additional post-processing, it is possible to obtain a wide range of 
mechanical and chemical properties. This can be accomplished through changing the polymer 
concentration, changing the fiber cross section, using a textile manufacturing process, polymer 
blending, coating the fibers in ECM, inclusion of nanomaterials, and more.  
Because of their versatile and useful properties, microfibers have specifically received a 
great amount of attention in 3D cell culturing and other biomedical applications. For surface type 
cell seeding, modifications to the topography and chemistry of the fiber’s surface can help to aid 
in cell adhesion and proliferation, whereas the mechanical and chemical properties of the fibers 
themselves play a significant role in the viability and behavior of cells encapsulated within. 
As microfibers gain prominence in 3D cell culturing and biomedical engineering 
applications, they continue to show promise for creating physiologically correct models and other 
clinical applications. Their continued contributions towards these fields shows their power as a 
tool capable of generating new technologies which can aid in biomedical research and provide new 
venues for designing highly complex but controlled experiments.  
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Microfibers have received much attention for their promise for creating flexible and highly 
relevant platforms for biomedical applications. This paper not only provides a unique and 
detailed overview of creating and designing fibers with tunable mechanical properties and 
surface topographies, but also covers fibers’ uses in biomedical fields, including tissue modeling, 
subcutaneous injection for therapeutic purposes, and drug delivery.  
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